LRRC1 and Hepatic fibrosis: To confirm whether targeting LRRC1 could suppress the progression of liver fibrosis in vivo, an adeno-associated virus (AAV)–shLRRC1 vector was injected into CCl4-induced mice via a high-pressure hydrodynamic method.